426
Views
38
CrossRef citations to date
0
Altmetric
Critical Care

Intoxications of the new psychoactive substance 5-(2-aminopropyl)indole (5-IT): A case series from the Swedish STRIDA project

, , , &
Pages 618-624 | Received 14 Feb 2014, Accepted 24 Apr 2014, Published online: 04 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Olof Beck, Lisa Franzén, Matilda Bäckberg, Patrick Signell & Anders Helander. (2016) Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clinical Toxicology 54:7, pages 568-575.
Read now
Derrick Lung, Nathan Wilson, Francois-Thibaut Chatenet, Clemence LaCroix & Roy Gerona. (2016) Non-targeted screening for novel psychoactive substances among agitated emergency department patients. Clinical Toxicology 54:4, pages 319-323.
Read now
Olof Beck, Lisa Franzen, Matilda Bäckberg, Patrick Signell & Anders Helander. (2015) Intoxications involving MDPV in Sweden during 2010–2014: Results from the STRIDA project. Clinical Toxicology 53:9, pages 865-873.
Read now
Matilda Bäckberg, Olof Beck & Anders Helander. (2015) Phencyclidine analog use in Sweden—intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project. Clinical Toxicology 53:9, pages 856-864.
Read now
Matilda Bäckberg, Olof Beck, Karl-Henrik Jönsson & Anders Helander. (2015) Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clinical Toxicology 53:7, pages 609-617.
Read now
Anders Helander, Olof Beck & Matilda Bäckberg. (2015) Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine. Clinical Toxicology 53:5, pages 446-453.
Read now
Matilda Bäckberg, Erik Lindeman, Olof Beck & Anders Helander. (2015) Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clinical Toxicology 53:1, pages 46-53.
Read now

Articles from other publishers (30)

Kimberly C. McKeirnanKavya VaitlaRubi GilbertCandace B. AndersonMegan R. Undeberg. (2023) Hypothermia as a Possible Symptom of Serotonin Toxicity: A Case Report. The Senior Care Pharmacist 38:6, pages 223-232.
Crossref
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, Ornella Corazza, Aurora Coppola & Gianluca Esposito. (2023) The novel psychoactive substances epidemic: A scientometric perspective. Addiction Neuroscience 5, pages 100060.
Crossref
Deborah Rudin, John D. McCorvy, Grant C. Glatfelter, Dino Luethi, Dániel Szöllősi, Tea Ljubišić, Pierce V. Kavanagh, Geraldine Dowling, Marion Holy, Kathrin Jaentsch, Donna Walther, Simon D. Brandt, Thomas Stockner, Michael H. Baumann, Adam L. Halberstadt & Harald H. Sitte. (2021) (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice. Neuropsychopharmacology 47:4, pages 914-923.
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 131 156 .
Deborah Rudin, Matthias E. Liechti & Dino Luethi. (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology 343, pages 113778.
Crossref
Fabrizio Schifano, Stefania Chiappini, Andrea Miuli, John Martin Corkery, Norbert Scherbaum, Flavia Napoletano, Davide Arillotta, Caroline Zangani, Valeria Catalani, Alessandro Vento, Mauro Pettorruso, Giovanni Martinotti, Di Giannantonio Massimo & Amira Guirguis. (2021) New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review. Experimental Neurology 339, pages 113638.
Crossref
Dino Luethi & Matthias E. Liechti. 2021. 5-HT2B Receptors. 5-HT2B Receptors 277 289 .
Simon D. Brandt, Laura Carlino, Pierce V. Kavanagh, Folker Westphal, Wolfgang Dreiseitel, Geraldine Dowling, Michael H. Baumann, Harald H. Sitte & Adam L. Halberstadt. (2020) Syntheses and analytical characterizations of novel (2‐aminopropyl)benzo[ b ]thiophene (APBT) based stimulants . Drug Testing and Analysis 12:8, pages 1109-1125.
Crossref
Anders Helander, Matilda Bäckberg & Olof Beck. (2020) Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PLOS ONE 15:4, pages e0232038.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Lea Wagmann, Simon D. Brandt, Alexander Stratford, Hans H. Maurer & Markus R. Meyer. (2019) Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases. Drug Testing and Analysis 11:2, pages 318-324.
Crossref
Dino Luethi, Karolina E. Kolaczynska, Luca Docci, Stephan Krähenbühl, Marius C. Hoener & Matthias E. Liechti. (2018) Pharmacological profile of mephedrone analogs and related new psychoactive substances. Neuropharmacology 134, pages 4-12.
Crossref
Matilda Bäckberg, Karl-Henrik Jönsson, Olof Beck & Anders Helander. (2018) Investigation of drug products received for analysis in the Swedish STRIDA project on new psychoactive substances. Drug Testing and Analysis 10:2, pages 340-349.
Crossref
Anders Helander & Matilda Bäckberg. 2018. New Psychoactive Substances. New Psychoactive Substances 461 473 .
Linda D. Simmler & Matthias E. Liechti. 2018. New Psychoactive Substances. New Psychoactive Substances 143 164 .
Robert Kronstrand, Davide Guerrieri, Svante Vikingsson, Ariane Wohlfarth & Henrik Gréen. 2018. New Psychoactive Substances. New Psychoactive Substances 495 541 .
Lea Wagmann & Hans H. Maurer. 2018. New Psychoactive Substances. New Psychoactive Substances 413 439 .
Ritva Karinen & Gudrun Høiseth. (2017) A literature review of blood concentrations of new psychoactive substances classified as phenethylamines, aminoindanes, arylalkylamines, arylcyclohexylamines, and indolalkylamines. Forensic Science International 276, pages 120-125.
Crossref
Annabel Vreeker, Babette G. van der Burg, Margriet van Laar & Tibor M. Brunt. (2017) Characterizing users of new psychoactive substances using psychometric scales for risk-related behavior. Addictive Behaviors 70, pages 72-78.
Crossref
Anders Helander. 2017. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation 83 99 .
A. Helander, M. Bradley, A. Hasselblad, L. Norlén, I. Vassilaki, M. Bäckberg & J. Lapins. (2017) Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45. British Journal of Dermatology 176:4, pages 1021-1027.
Crossref
Lea Wagmann, Simon D. Brandt, Pierce V. Kavanagh, Hans H. Maurer & Markus R. Meyer. (2017) In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks. Toxicology Letters 272, pages 84-93.
Crossref
Sean Sassano-Higgins, Dave Baron, Grace Juarez, Neevon Esmaili & Mark Gold. (2016) A REVIEW OF KETAMINE ABUSE AND DIVERSION. Depression and Anxiety 33:8, pages 718-727.
Crossref
David M. Wood & Paul I. Dargan. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse 208 218 .
Simon Elliott. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse 94 126 .
Markus R. Meyer & Hans H. Maurer. (2016) Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices – Where do we stand today?. Analytica Chimica Acta 927, pages 13-20.
Crossref
Markus R. Meyer, Madeleine Pettersson Bergstrand, Anders Helander & Olof Beck. (2016) Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes. Analytical and Bioanalytical Chemistry 408:13, pages 3571-3591.
Crossref
Elli Tyrkkö, Mikael Andersson & Robert Kronstrand. (2016) The Toxicology of New Psychoactive Substances. Therapeutic Drug Monitoring 38:2, pages 190-216.
Crossref
Séverine Férec, Isabelle Leborgne, Chloé Bruneau, Joanna Bourgine, Xavier Valette, Chadi Abbara, Bénédicte Lelièvre, David Boels, Marie Bretaudeau-Deguigne & Alain Turcant. (2016) Severe serotoninergic syndrome after ingestion of α-methyltryptamine. Toxicologie Analytique et Clinique 28:1, pages 71-78.
Crossref
Julie A. Marusich, Kateland R. Antonazzo, Bruce E. Blough, Simon D. Brandt, Pierce V. Kavanagh, John S. Partilla & Michael H. Baumann. (2016) The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue. Neuropharmacology 101, pages 68-75.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.